Navigation Links
Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum
Date:2/8/2011

MIAMI, Feb. 8, 2011 /PRNewswire/ -- Attendees at the 2011 Pharmaceutical Care Management Association (PCMA)'s Managed Markets Educational Forum today heard Prime Therapeutics' President and CEO Eric Elliott speak about the critical changes facing pharmaceutical companies and pharmacy benefit managers as health care reform is implemented, industry consolidation increases, a greater number of generics enter the market and the pipeline of new treatments shrinks. Prime Therapeutics is a pharmacy benefit management (PBM) company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members.

"In this time of great change, the industry needs to address the three key areas of cost, quality and access. We need to work together to help patients safely navigate these changes, so that we may continue to deliver the right drugs, at the right time, at affordable prices," Elliott told attendees.

In his keynote address, Elliott spoke about how the industry has evolved and delivered improvements to patient health over the past several decades. In the coming years as more than 30 million patients join the health system, there will be a greater focus on providing higher quality care for patients while increasing value.

"While we may not all agree on each provision of the health care reform law, there are many provisions encouraging better outcomes and better cost management for our patients and clients," said Elliott. "There is an enormous potential to close gaps in care in our country. Whether the potential is realized will depend to a significant degree on how well we do helping patients access and stick to their medications, while managing costs."

Delivered to an audience of pharmaceutical manufacturers and other industry experts, Elliott's speech was the meeting's opening keynote address. The first-annual Managed Markets Educational Forum brings together leaders in the pharmaceutical and pharmacy benefits industries to discuss essential PBM, specialty pharmacy and payer issues.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to nearly 17 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 12 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Greenways PrimeSUITE EHR Featured at IHE North America Connectathon
2. Greenways PrimeSUITE Endorsed by Allina Hospitals & Clinics
3. Prime Healthcare Converts System-Wide to Masimo rainbow SET Technology
4. Columbia University Students Learn About Pharmacy Benefit Management From Prime Therapeutics President and CEO
5. Prime Therapeutics Receives 2011 TIPPS Certification
6. Greenways PrimeSUITE Receives ONC-ATCB 2011/2012 Certification
7. Prime Therapeutics Announces URAC Accreditation
8. Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care
9. Massachusetts Regional Extension Center Selects Greenways PrimeSuite
10. Nigerian Association of Pharmacists and Pharmaceutical Scientists in America (NAPPSA) Announces Prime Vendor Agreement with H. D. Smith
11. Siemens Primed to Help Customers Achieve Newly-Defined Criteria for Meaningful Use of an Electronic Health Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... , May 10, 2017  The Corporate ... or employees of sleep therapy clinics to call ... sleep therapy clinic is involved in a substantial ... interested in hearing from an employee of a ... in a kickback scheme to provide medical practice groups ...
(Date:5/10/2017)... CSSi, the global leader in patient recruitment, ... is proud to announce the launch of its newly ... both enriched content and a customized layout that provides ... already well-established position as the top global patient recruitment ... months of hard work, we are delighted to officially ...
(Date:5/9/2017)... WASHINGTON , May 9, 2017  Demonstrating ... the board of directors for the Pharmaceutical Research ... criteria for membership. Biopharmaceutical companies will now have ... in order to be eligible to join PhRMA. ... criteria, the board is sending a clear message ...
Breaking Medicine Technology:
(Date:5/27/2017)... ... , ... In any business, follow up is critical to success. It is ... presenting treatment, there will always be some patients who can’t or won’t make a ... practices when it comes to presenting treatment. After the patient leaves, most practices ...
(Date:5/27/2017)... ... May 27, 2017 , ... Most us are familiar ... a new study from the Osteoarthritis Initiative shows that certain people who ... Knowing this in advance may give doctors the opportunity to treat patients before the ...
(Date:5/26/2017)... YORK, NY (PRWEB) , ... May 26, 2017 ... ... Board (SAB) met this week to review more than eighty-nine grant submissions ... experienced and emerging young scientists in the Parkinson’s field.     , The American Parkinson ...
(Date:5/26/2017)... , ... May 26, 2017 , ... ... announce a new educational seminar to focus on current legislative activity and the ... will begin at 1 p.m. Sunday, Sept. 10, and will continue through Monday, ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device ... consistent, browser-based interface for diagnostic device operations. With this platform, initializing devices and ...
Breaking Medicine News(10 mins):